Compare American Well Corp (AMWL) vs Altria Group Inc (MO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
American Well Corp vs Altria Group Inc — how do they compare? American Well Corp trades at $9.7 (market cap $165.58M), while Altria Group Inc trades at $72 (market cap $119.88B). The key difference: Altria Group Inc is far larger — about 724× American Well Corp's market cap, and Altria Group Inc pays a 5.91% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | MO | |
|---|---|---|
Market Cap | $165.58M | $119.88B |
Sector | Health | Consumer Staples |
52-Week High | $9.91 | $74.55 |
52-Week Low | $3.78 | $54.72 |
Enterprise Value | -$9.66M | $140.95B |
Dividend Yield | — | 5.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
Altria Group (MO) trades at $71.77, up 0.25% on the day, with a bullish technical signal and strong analyst support (16 buy ratings). The stock exhibits robust fundamentals, including a P/E of 14.99, net income margin of 39.52%, and consistent dividend payments, highlighted by a recent $1.06 dividend. Revenue remains stable around $20.1B, though net income dipped to $6.95B in 2025 from $11.3B in 2024. Positive cash flow of $1.33B in 2025 supports financial health, while technical indicators show support at $71 and resistance at $73.
Outlook: MO offers a compelling dividend yield and defensive appeal amid market volatility, but faces risks from declining smoking trends and regulatory pressures. Analyst consensus price target is $71.00, with potential upside to $79.00. Investors should weigh high debt levels and competitive threats against strong cash flow and brand loyalty for long-term income stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
